Difference between revisions of "Main Page"
Jump to navigation
Jump to search
m |
m |
||
| Line 1: | Line 1: | ||
| − | + | ='''HemOnc.org - A Free Hematology/Oncology Reference'''= | |
| − | Created by oncologists as a knowledge base for providers, this site contains reference notes prepared by their peers and allows people to share wisdom and insights from their own clinical experiences for the benefit of all. | + | Created by oncologists as a knowledge base for providers, this site contains reference notes prepared by their peers and allows people to share wisdom and insights from their own clinical experiences for the benefit of all. This shared online notebook will continue to evolve and grow to meet the needs of the community because users such as yourself are able to refine and build upon existing content. |
{| border="1" style="text-align:center;" | {| border="1" style="text-align:center;" | ||
| Line 10: | Line 10: | ||
|[[Acute lymphocytic leukemia | Acute lymphocytic leukemia (ALL)]] | |[[Acute lymphocytic leukemia | Acute lymphocytic leukemia (ALL)]] | ||
|[[Acute myeloid leukemia | Acute myeloid leukemia (AML)]] | |[[Acute myeloid leukemia | Acute myeloid leukemia (AML)]] | ||
| − | |[[Chronic lymphocytic leukemia | Chronic lymphocytic leukemia (CLL)]] | + | |[[Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL) | Chronic lymphocytic leukemia (CLL/SLL)]] |
|[[Chronic myelogenous leukemia | Chronic myelogenous leukemia (CML)]] | |[[Chronic myelogenous leukemia | Chronic myelogenous leukemia (CML)]] | ||
|- | |- | ||
| Line 58: | Line 58: | ||
Any information that one feels would be helpful to other oncology providers is welcome. Visit [[how to contribute]] for more details. '''For now, all information here should be considered to be "beta"--that is, in the development phase. By using this site, you are indicating that you have read and agree with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]].''' Initial priorities of this project will consist of: | Any information that one feels would be helpful to other oncology providers is welcome. Visit [[how to contribute]] for more details. '''For now, all information here should be considered to be "beta"--that is, in the development phase. By using this site, you are indicating that you have read and agree with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]].''' Initial priorities of this project will consist of: | ||
| − | #Creating a database of [[chemotherapy]] | + | #Creating a database of [[Drug index | chemotherapy agents and other medications]]. |
#Creating an index of [[diseases]]. | #Creating an index of [[diseases]]. | ||
| − | #Creating a [[ | + | #Creating a [[Diseases | list of chemotherapeutic regimens]] and references to primary literature (PubMed and direct links to the abstracts/full articles). |
#Sample order sets and examples of supportive medications used with treatment regimens | #Sample order sets and examples of supportive medications used with treatment regimens | ||
#Aggregating [[External links|useful links]] to existing resources by disease, such as information about prognosis, clinical calculators, staging, and patient resources. | #Aggregating [[External links|useful links]] to existing resources by disease, such as information about prognosis, clinical calculators, staging, and patient resources. | ||
| Line 68: | Line 68: | ||
#Establishing homepages for ongoing clinical trials that contain information and sites of participation | #Establishing homepages for ongoing clinical trials that contain information and sites of participation | ||
#Checklists for common clinical scenarios/diseases | #Checklists for common clinical scenarios/diseases | ||
| − | #Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects | + | #Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects |
| − | #List of [[ICD-9 codes]]. | + | #List of [[ICD-9 codes]] |
| + | #[[Pathology | Pathology references]], including histology images and information about immunohistochemistry and CD markers. | ||
The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as [http://en.wikipedia.org/wiki/Main_Page Wikipedia], will significantly help ease-of-use and navigation. | The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as [http://en.wikipedia.org/wiki/Main_Page Wikipedia], will significantly help ease-of-use and navigation. | ||
If you would like to contribute, please create an account in the upper right corner, and contact [email protected] so that your account can be set up with the necessary rights. Due to the sensitive nature of the information contained within this site, unverified users will not be allowed to edit articles. | If you would like to contribute, please create an account in the upper right corner, and contact [email protected] so that your account can be set up with the necessary rights. Due to the sensitive nature of the information contained within this site, unverified users will not be allowed to edit articles. | ||
Revision as of 15:07, 5 April 2012
HemOnc.org - A Free Hematology/Oncology Reference
Created by oncologists as a knowledge base for providers, this site contains reference notes prepared by their peers and allows people to share wisdom and insights from their own clinical experiences for the benefit of all. This shared online notebook will continue to evolve and grow to meet the needs of the community because users such as yourself are able to refine and build upon existing content.
Any information that one feels would be helpful to other oncology providers is welcome. Visit how to contribute for more details. For now, all information here should be considered to be "beta"--that is, in the development phase. By using this site, you are indicating that you have read and agree with the terms set forth in the disclaimer. Initial priorities of this project will consist of:
- Creating a database of chemotherapy agents and other medications.
- Creating an index of diseases.
- Creating a list of chemotherapeutic regimens and references to primary literature (PubMed and direct links to the abstracts/full articles).
- Sample order sets and examples of supportive medications used with treatment regimens
- Aggregating useful links to existing resources by disease, such as information about prognosis, clinical calculators, staging, and patient resources.
Additional possibilities for this project may include:
- Creating summaries of pivotal clinical trials
- Establishing homepages for ongoing clinical trials that contain information and sites of participation
- Checklists for common clinical scenarios/diseases
- Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects
- List of ICD-9 codes
- Pathology references, including histology images and information about immunohistochemistry and CD markers.
The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as Wikipedia, will significantly help ease-of-use and navigation.
If you would like to contribute, please create an account in the upper right corner, and contact [email protected] so that your account can be set up with the necessary rights. Due to the sensitive nature of the information contained within this site, unverified users will not be allowed to edit articles.